Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome

Miller Fisher syndrome (MFS) is a variant of Guillain-Barré syndrome. Delayed facial palsy (DFP) is a symptom that occurs after other neurological symptoms begin to recover within four weeks from the onset of MFS. As there have been few detailed reports about DFP in MFS cases treated with additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Shohei, Tokuhara, Yusuke, Hiratsuka, Mari, Yoshizumi, Kazuki, Ukon, Shinichiro, Kasama, Shuhei, Takeda, Masanaka, Funakoshi, Kei, Kimura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751713/
https://www.ncbi.nlm.nih.gov/pubmed/36385049
http://dx.doi.org/10.2169/internalmedicine.9430-22
_version_ 1784850539353210880
author Watanabe, Shohei
Tokuhara, Yusuke
Hiratsuka, Mari
Yoshizumi, Kazuki
Ukon, Shinichiro
Kasama, Shuhei
Takeda, Masanaka
Funakoshi, Kei
Kimura, Takashi
author_facet Watanabe, Shohei
Tokuhara, Yusuke
Hiratsuka, Mari
Yoshizumi, Kazuki
Ukon, Shinichiro
Kasama, Shuhei
Takeda, Masanaka
Funakoshi, Kei
Kimura, Takashi
author_sort Watanabe, Shohei
collection PubMed
description Miller Fisher syndrome (MFS) is a variant of Guillain-Barré syndrome. Delayed facial palsy (DFP) is a symptom that occurs after other neurological symptoms begin to recover within four weeks from the onset of MFS. As there have been few detailed reports about DFP in MFS cases treated with additional immunotherapy, we investigated three cases of DFP in MFS treated with additional steroid therapies. The duration of facial palsy in our cases was 12-24 days. No severe adverse effects were observed. Although adverse side effects should be carefully monitored, additional steroid therapy might be a treatment option for MFS-DFP.
format Online
Article
Text
id pubmed-9751713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-97517132022-12-22 Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome Watanabe, Shohei Tokuhara, Yusuke Hiratsuka, Mari Yoshizumi, Kazuki Ukon, Shinichiro Kasama, Shuhei Takeda, Masanaka Funakoshi, Kei Kimura, Takashi Intern Med Case Report Miller Fisher syndrome (MFS) is a variant of Guillain-Barré syndrome. Delayed facial palsy (DFP) is a symptom that occurs after other neurological symptoms begin to recover within four weeks from the onset of MFS. As there have been few detailed reports about DFP in MFS cases treated with additional immunotherapy, we investigated three cases of DFP in MFS treated with additional steroid therapies. The duration of facial palsy in our cases was 12-24 days. No severe adverse effects were observed. Although adverse side effects should be carefully monitored, additional steroid therapy might be a treatment option for MFS-DFP. The Japanese Society of Internal Medicine 2022-11-15 2022-11-15 /pmc/articles/PMC9751713/ /pubmed/36385049 http://dx.doi.org/10.2169/internalmedicine.9430-22 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Watanabe, Shohei
Tokuhara, Yusuke
Hiratsuka, Mari
Yoshizumi, Kazuki
Ukon, Shinichiro
Kasama, Shuhei
Takeda, Masanaka
Funakoshi, Kei
Kimura, Takashi
Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
title Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
title_full Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
title_fullStr Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
title_full_unstemmed Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
title_short Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
title_sort additional steroid therapy for delayed facial palsy in miller fisher syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751713/
https://www.ncbi.nlm.nih.gov/pubmed/36385049
http://dx.doi.org/10.2169/internalmedicine.9430-22
work_keys_str_mv AT watanabeshohei additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT tokuharayusuke additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT hiratsukamari additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT yoshizumikazuki additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT ukonshinichiro additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT kasamashuhei additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT takedamasanaka additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT funakoshikei additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome
AT kimuratakashi additionalsteroidtherapyfordelayedfacialpalsyinmillerfishersyndrome

Ejemplares similares